Ensure healthy lives and promote well-being for all at all ages

This chapter aligns with several SDG goals. Goal 3: Good Health and Well-Being: the chapter discusses the poor health status and health disparities faced by Indigenous populations globally (higher rates of infant mortality, maternal mortality, malnutrition etc.) and advocates for targeted policy responses and improved access to healthcare services. Goal 10: the chapter discusses the social, economic, and political marginalization of Indigenous peoples worldwide, describing how Indigenous communities are often denied self-determination, face ongoing loss of land and resources, and experience systemic discrimination. Goal 15: Life on Land: the chapter discusses the close relationship between the health of Indigenous peoples and the health of their traditional lands and ecosystems. It highlights the importance of biodiversity conservation and the need to recognize the rights of Indigenous communities to their ancestral territories and natural resources.

World Hepatitis day July 28th, 2024. It's time for action.

This Article supports SDG 3 by assessing the effectiveness of a hepatitis B model of care in Australia, suggesting that the model, involving primary health care, could be rolled out nationally or internationally. The authors suggest that the model could have positive implications particularly for low-income and middle-income countries.
This Article supports SDG3 by evaluating the cost-effectiveness of integrating simplified hepatitis C virus testing with HIV PrEP treatment among men who have sex with men.
This Article supports SDG 3 by evaluating a hepatitis B screening programme in which members of the West African community in the Bronx were offered hepatitis B testing when they attended a blood pressure clinic visit following an educational intervention about hypertension. Almost all participants accepted to have hepatitis B screening, showing the effectiveness of its being linked to blood pressure testing.
This Article supports SDG 4 by documenting significant improvements in fibrosis-based liver disease burden with direct-acting antivirals, among a cohort of patients with chronic hepatitis C.
This study supports SDG 3 by analyzing expenditures on hepatitis B treatments, promoting better health resource management.

International Day of Friendship 2025

Elsevier,

Metabolic Steatotic Liver Disease: Current Knowledge, Therapeutic Treatments, and Future Directions, 2024, Pages 261-275

This content aligns with Goal 3: Good Health as this chapter will review the aspects of combined viral hepatitis and FLD, including prevalence, risk factors, natural history, pathogenesis, and management to help inform the reader of the complexity of these liver diseases.

Pages